Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Business
Jasper Jolly

GSK signs £50m deal with Oxford University on cancer vaccines

GSK logo
GSK is Britain’s second-biggest drugmaker behind AstraZeneca. Photograph: Dado Ruvić/Reuters

GSK has said it will spend £50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.

The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.